Even without the settlement SPEX +7% is way undervalued:
2.9m o/s. market cap is $6m
Total Assets $14m, Total liabilities $5m, Net assets (assets minus debt)= $9m ,this alone makes it undervalued vs $6 market cap. ,Assets/Debt ratio=3,very solid.
Impairment of goodwill and patent portfolio $40m
settlement might have a huge affect the number of potential licensees to their portfolio (next month or before). worth following.imo.
especially after those developments: insider buying too and now Compliance with Nasdaq Listing Requirements,and there are only 2.9m O/S. Singed an Executes Joint Venture Agreement 2 weeks ago,and executing on the new strategy announced in recent shareholder letter.
From YMB.: dtrader12 • Apr 1, 2016 2:26 PM
S"PEX settlement details
Sorry could not post link in last post:
Another milestone for 2016 includes the continued discussions with RPX, as are required under the partial license sold to RPX in November of 2015. Spherix is committed to continuing those discussions in good faith and we hope to reach a fair and reasonable license. By agreement, these discussions can continue until May 23rd of this year. If an agreement is not reached by May 23rd, then the agreed "stay" on litigation expires and the number of potential licensees to our portfolio increases significantly"
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
